Fabric with active principles and relevant recharging method of the active principles

Description

[0001] The present invention refers to a fabric with active principles and to a recharging method of said principles having the main aim to prevent and/or to give the first cures to the diabetic foot. Between the diabetes complications are known the problems to the feet caused to ulcers, accidental injuries, micro-traumas, wounds also light, callosity and infections. Are known the grave damages and the risks of grafting of important complications from light wounds in the diabetic patient. The persons with these pathologies have a reduced flux of blond in the inferior arts, in particular from the knee to the foot, owing to a stricture of the arteries. Moreover, the diabetes gives a progressive destruction of the nerves that arrive to the foot and to a skin degeneration, that becomes dry and inflexible, so easy to be subjected to wounds. The concomitance of these events determines infections often careless and minimal realized to the diabetic patient, this due also to a minor sensibility of the nervous terminations of the foot. The degenerative forms created to a light wound are, owing to the complications given to the metabolic, circulatory and neurological alterations, not to disregard as they easily evolve in serious pathologies, unfortunately favourite to long times for healing the wounds in the diabetic patient, with consequent increasing of risk of bacterial, viral and mycotic infections. The complications of a normal disregarded ulceration are one of the more frequent causes of admission to hospital for this pathology. The non-prevention and non-care of that known as diabetic foot determines the claudication and, in the grave cases, the amputation of the art. A consistent percentage of diabetic persons are subjected to ulcerations to the feet that prolong in the time can grow worse. To have an idea of the problem are cited the data of the Health World Organization where are counted in one hundred and twenty million the diabetic persons in year 1996 and it is estimated in three hundred million the number of diabetic persons in year 2025, where on an average the 15% will have ulcerations to the feet with complications. Always from the cited sources are known data that counted that for one hundred diabetic patients with amputations eighty-four have had as cause of the amputation an ulceration to a foot grows worse in time. Moreover, over the 50% of all the amputations of the lower limbs regards diabetic patients. Currently are not known local preventive applications to be constantly used to prevent, cure or reinforce the defences of the foot of the diabetic patient so to avoid the complications previous described. The sole forms of prevention in this delicate sector are given prevalently based onto mode of behaviour as the careful test of the food, the sanitary education for observation of hygienic rules, the using of correct shoes and the application of topical remedy at the appearing of the first ulcerations. The invention, instead, realizes a therapeutic remedy able to prevent the formation of ulcerations and to favourite the recovery of wounds eventually formed. The invention creates a fabric, for specific application in this pathology, impregnated with substances with synergetic action and gradual release, and a recharging method of said active substances when these have lost their efficacy in time. The recharging of the active principles to the fabric permits a reusing of the specific fabric and it permits to have a set of clothes with controlled release of the active substances. The invention consists of a fabric 1 in lycra fibres and micro-fibres (known with the trade "meryl"), in variable percentages for application of this kind, that in actuation has the form of stocking 2, pantyhose 3, sock 4, winding bandage with closed border 5, bandage or plaster 6. This type of fabric, with new application for the specific pathology of the diabetic foot, has the characteristic to have fibres with minor or equal subtlety to ten micrometer. So the fibres of this fabric are of inferior diameter to that of the silk, that have a subtlety of the fibres of twelve micrometer of the cotton with subtlety of the fibres of thirteen and half micrometer of the cashmere with fibres diameter dimension of fifteen micrometer and of the wool with fibres diameter dimension of seventeen micrometer. The application of this characteristic of the invention is of big importance for the diabetic foot such as more the thread is thin minor are the damages to abrasion of the fabric onto the skin. So an extremely smooth fabric is obtained that no creates micro-abrasions onto the inelastic skin and dry of the diabetic patient. In other embodiment of the invention the fabric 1 is provided in the woof of thin silver yarns 7 with function anti-bacteric and bacteriostatic. To avoid grazes from sewing the invention, in the form of the stocking 2, pantyhose 3, sock 4, has a sewing with flat folding 8 in the anterior part of the stocking, imperceptible to the touch. The fabric 1, moreover, ha elastic property (elasticity of 99-100%) so to not obstruct the venous flux, to not worsening the occlusive peripheral arterypatia and to favourite the local microcirculation. Unlike to the other synthetic fibres, moreover, it has capacity of umidity absorption, low rate of water retention and, differently to the natural fibres, quick time of drying. These characteristic have like resulting capacity to oppose the formation of fungus and to limit the bacteric growth. To the fabric 1 are then added active substances with application method to the fabric and recharging method of new conception. To the fabric 1 is bound a glycoprotein (9) (pseudoalteromonos ferment extract, known with the trade "antarcticine") synthesized to a bacteria (pseudoalteromanas antartica NF3) of the species Gram-negative, with composition of the fat acids and to the proteinic outline typical of the alteromonas family. This substance during the cellular growth produces a glycoprotein exopolymer composed of the 76-86% of proteins and to 8-14% of sugar, in base of the used means. This active substance have had use, previous to the invention, like a cosmetic humectant and emollient ingredient and like a substance with crioprotective property. Said active principle, of new and original application in the treatment of the diabetic foot, has important property that opposed the dryness of the skin typical of the diabetic patient. It gives, infact, the coesion between the spinous and germinativum stratum favouring the madding and the folding of the interkeratociti liquids, so as estimated through the compression studies of the isotherms and of the multilayer of the Langmuir balance. Moreover, said substance stimulates the growth of the human skin fibroblast in the tests in vitro without the growth of the keratinociti, so acting onto the micro-ulcerations of the skin to their first turning up and onto all the cute surface, from the knee to the foot. Moreover, the active principle given to the cited substance increases the formation of elastin and of collagen type I and type IV with increasing of the cute hydration of at least the 45% in the twelve subsequent hours in comparison with a sample of skin not treated or treated with cream with the only placebo effect. This substance is inserted in the wet fabric in a quantity of at least 1 mg/ml. To the fabric 1 is then added, without order of insertion to the fabric but with modality of charge and recharge following described, an exapeptide (10) from the alpha chain (known with trade "serilesine"). This peptide increases the adhesion of the cells, favours the cellular proliferation and betters the microcirculation such as it favours the angiogenesis. This active substance is added to the wet fabric 1 in quantity at least of 0,05 mg/ml. Also this last substance is never previous used for the use in pathology such that of the diabetic foot. Both these substances are previous used in the cosmetic field. So they do not present toxicity problems and they are not to be considered drugs to be prescribed with prescription. In particular they do not have, such the made tests has certified, cytotoxicity on human fibroblasts, cytotoxicity on keratinocity, they have no given toxicity prove in the tests of hemolysis, in the tests of genotoxicity, i.e. in the Ames tests, and they are not irritating as valuing with the het-cam for the valuation of the potential ocular irritation. The used substances in the described concentrations do not create irritation to the skin, sensitization phenomenon, ocular irritation and oral and skin toxicity. These substances 9 and 10 are moreover bound to the fabric 1 essentially for coulomb bond, being they with prevalent positive charge whereas the fabric has fibres with negative charge for own constitution. The substances 9 and 10 are mixed into microcapsules 11 soluble in water. The fabric 1 is then washed in water at 50°C. Ending this working the water is discharged and the fabric is wet with clean water to which is added a mordanting assistant 12, the Nylofixam PM (sold by Clariant) that has the function to bound the substances contained in the microcapsules 11 to the aminic group of the fabric 1, by means of the polarization that favours the union between the fabric 1 and the substances 9 and 10 into the microcapsules. The fixer 12 is then added in proportion of 4% of the weight of the fabric 1 to treat. Then are introduced in the bath the microcapsules 11 in the dose previous described and in total quantity of the 6% of the weight of the fabric. After ten minutes is added a cationic product 13, i.e. softenol 70 (sold by Lautex) that contributes also it to bound the microcapsules 11 with the fabric 1. The "lautex" is added in percentage of 2% of the weight of the fabric. After ninety minutes the bath is let out and the fabric 1 is centrifuged and dry, ready to be used. In the version for the domestic use the microcapsules 11 and the fixers 12 and 13 to the fabric 1 are sold in pre-dosed packaging, to can use the stocking 2, the pantyhose 3, the sock 4, the winding bandage 5, the bandage or plaster 6. To actuate the recharging of the active substances 9 and 10 to the fabric 1 for domestic three grams of substances 9 and 10 in microcapsules 11 are brought and they are dissolved into 300-500 ml. of water, after to have washed the used fabric 1, at a temperature inferior to 40°C. The pantyhose, or the sock or the other forms of the fabric 1 are then left in soaking for 15-20 minutes. These products are then dry in air. After this treatment the fabric 1 have an uniform distribution of the active principles. With pre-determined times are provided rechargings, also conserving the active principles effectiveness till the third days of use. The invented product conserves the active principles also after three washings. However, it is suggested the daily washing and the recharging after three days from the first use with the method above described. The simple application of a cream with active principles does not reach the useful results for the diabetic foot pathology such as the results obtained with the invention such as the friction of the foot with the conventional pantyhose creates, during the walk, frictions that take off the cream instead of makes it to absorb to the skin of the foot and neither the occlusive bandages with cream and gauzes are not to be used if no with the patient in bed. The invention is so to be used in the daily without constraints and/or changing to the style of life of the patient. The invention in the application in the form of application also winding bandage 5, cicatrizant bandage or plaster 6 have application also remedy for the bedsores and/or light wounds.. The cicatrizant action, the better of the micro-circulation and the effect on the derma determine a quick healing of these woods without collateral effects. The invention is illustrated in a merely indicative way in the drawings of sheets 1 and 2. In sheet 1 figure 1 is view of an example of production like a stocking. In the same table 1 the figure 2 is view of an application like a stock. Figure 3 is view of the version like a pantyhose. Figure 4 is view of the version of winding bandage with closed profile. Figure 5 is view of the version of bandage or plaster. In sheet 2 are illustrated some sequences of the recharging phase of the active principles of the invention. In detail figure 6 is view of the immersion phase. Figure 7 is view of the invention soaks in water with the active principles.

Claims

1. A fabric with active principles (1), said fabric consisting of lycra fibres and micro-fibres, characterized in that it has distributed along the fibres, as active principles, a glycoprotein (9) and a hexapeptide (10), wherein said active principles prevent and/or give the first cures to the diabetic foot.

2. The fabric according to claim 1, in which said glycoprotein (9) is the Pseudoalteromonas ferment extract, synthesized by the bacteria Pseudoalteromonas Antarctica NF3, and said hexapeptide (10) is the hexapeptide from the alpha chain serilesine.

3. The fabric according to anyone of claims 1-2, in which said active principles, glycoprotein (9) and hexapeptide (10), are mixed into microcapsules (11) soluble in water.

4. The fabric according to anyone of the preceding claims, in which said active principles, glycoprotein (9) and hexapeptide (10), are bound to the fabric essentially for coulomb bonds.

5. The fabric according to anyone of the preceding claims, said fabric having the production form of a stocking (2), of a pantyhose (3), of a sock (4), of a winding bandage with closer border (5) of a bandage or plaster (6) to realize a continuous and persistent contact with the skin of the diabetic patient.

6. A method for recharging the active principles into a fabric according to anyone of claims 1-5, characterized in that the recharging or the first charging of the washed fabric is actuated bathing the fabric (1) with clean water to which is added a fixer, Nylofixan PM (12), in proportion of 4% of the weight of the fabric (1) to be treated, subsequently putting in the bath the microcapsules (11), containing the active principles (9) and (10), in a total quantity equal to 6% of the weight of the fabric, then, after ten minutes, a the cationic product Softenol 70 is added in percentage of 2% of the weight of the fabric and, after ninety minutes, the bath is discharged and the fabric (1) is centrifuged and dried.

7. A method for recharging the active principles into a fabric according to anyone of claims 1-5, characterized in that it provides, for the recharging in domestic use, the use of three grams of the substances (9) and (10) into the microcapsules (11), dissolved into 300-500 ml of water at a temperature inferior to 40°C, and subsequent soaking of the fabric (1) for at least fifteen minutes.

Ansprüche

1. Mit Wirkstoffen beladenes Gewebe (1), wobei das benannte Gewebe aus Lycra-Fasern und Mikrofasern besteht, dadurch gekennzeichnet, daß als Wirkstoffe ein Glykoprotein (9) und ein Hexapeptid (10) entlang dessen Fasern verteilt sind, worin die benannten Wirkstoffe dem diabetischen Fuß vorbeugen und/oder dem diabetischen Fuß die ersten Behandlungen bieten.

2. Gewebe nach Anspruch 1, worin das benannte Glykoprotein (9) der Gärextrakt Pseudoalteromonas ist, der von den Bakterien Pseudoalteromonas Antarctica NF3 synthetisiert wird, und das benannte Hexapeptid (10) das Hexapeptid aus der Alpha-Kette Serilesin ist.

3. Gewebe nach irgendeinem der Ansprüche 1-2, worin die benannten Wirkstoffe, Glykoprotein (9) und Hexapeptid (10), in wasserlöslichen Mikrokapseln vermischt werden.

4. Gewebe nach irgendeinem der vorherigen Ansprüche, worin die benannten Wirkstoffe, Glykoprotein (9) und Hexapeptid (10), wesentlich durch Coulomb-Bindungen mit dem Gewebe gebunden sind.

5. Gewebe nach irgendeinem der vorherigen Ansprüche, wobei das benannte Gewebe die Herstellungsform eines Strumpfs (2), einer Strumpfhose (3), einer Socke (4), einer Bandage mit geschlossenem Rand (5) oder eines Verbands oder Pflasters (6) aufweist, um kontinuierlich und dauerhaft in Berührung mit der Haut des diabetischen Patienten zu stehen.

6. Verfahren zum Wiederaufladen der Wirkstoffe in ein Gewebe nach irgendeinem der Ansprüche 1-5, dadurch gekennzeichnet, daß das Wiederaufladen oder erste Laden des gewaschenen Gewebes durchgeführt wird, indem das Gewebe (1) in sauberem Wasser getaucht wird, zu dem ein Fixiermittel, Nylofixan PM (12), in einem Anteil von 4% des Gewichts des zu behandelnden Gewebes (1) zugesetzt wird, dann werden die die Wirkstoffe (9) und (10) enthaltenden Mikrokapseln (11) in einer Gesamtmenge von 6% des Gewebegewichts ins Bad gelegt, nach zehn Minuten wird das kationische Produkt Softenol 70 in einem Prozentanteil von 2% des Gewebegewichts zugesetzt, und nach neunzig Minuten wird das Bad entlassen und das Gewebe (1) wird zentrifugiert und getrocknet.

7. Verfahren zum Wiederaufladen der Wirkstoffe in ein Gewebe nach irgendeinem der Ansprüche 1-5, dadurch gekennzeichnet, daß es für das Wiederaufladen zur Hausanwendung den Einsatz von drei Grammen der Stoffe (9) und (10) in den Mikrokapseln (11) vorsieht, die in 300-500 ml Wasser bei einer Temperatur unter 40°C gelöst werden, dann wird das Gewebe (1) für mindestens fünfzehn Minuten einweichen lassen.

Revendications

1. Etoffe chargée de principes actifs (1), ladite étoffe comprenant des fibres de lycra et des micro-fibres, caractérisée en ce que une glycoprotéine (9) et un hexapeptide (10) sont distribués le long de ses fibres en tant que principes actifs, où lesdits principes actifs préviennent et/ou représentent les premiers soins pour le pied diabétique.

2. Etoffe selon la revendication 1, où ladite glycoprotéine (9) est l'extrait fermenté de Pseudoalteromonas, synthétisé par les bactéries Pseudoalteromonas Antarctica NF3, et ledit hexapeptide (10) est l'hexapeptide de la chaîne alpha de sérilésine.

3. Etoffe selon une quelconque des revendications 1-2, où lesdits principes actifs, glycoprotéine (9) et hexapeptide (10), sont mélangés dans microcapsules (11) hydrosolubles.

4. Etoffe selon une quelconque des revendication précédentes, où lesdits principes actifs, glycoprotéine (9) et hexapeptide (10), sont liés à l'étoffe essentiellement par des liens de Coulomb.

5. Etoffe selon une quelconque des revendications précédentes, ladite étoffe ayant la forme de fabrication de bas (2), de collant (3), de chaussette (4), de bandage à bordure fermée (5), d'une bande ou d'un sparadrap (6) pour réaliser un contact continu et durable avec la peau du patient diabétique.

6. Méthode pour la recharge en principes actives d'une étoffe selon une quelconque des revendications 1-5, caractérisée en ce que la recharge ou première charge de l'étoffe lavée est réalisée en baignant l'étoffe avec eau propre à laquelle on ajoute un fixateur, Nylofixan PM (12), dans une proportion de 4% du poids de l'étoffe (1) à traiter, ensuite en déposant dans le bain les microcapsules (11) contenant les principes actifs (9) et (10), dans une quantité totale de 6% du poids de l'étoffe, puis après dix minutes on ajoute le produit cationique Softenol 70 dans un pourcentage de 2% du poids de l'étoffe, et après quatre-vingt-dix minutes on décharge le bain et on centrifuge et sèche l'étoffe (1).

7. Méthode pour la recharge en principes actives d'une étoffe selon une quelconque des revendications 1-5, caractérisée en ce que pour la recharge pour emploi domestique elle envisage l'utilisation de trois grammes des substances (9) et (10) dans les microcapsules (11), dissous dans 300-500 ml d'eau à une température inférieure à 40°C, et ensuite le trempage de l'étoffe (1) pour au moins quinze minutes.

Drawing